Promoting Innovation in Drug Development: Understanding the Current Regulatory Environment Nicholas S. Downing, MD (with Nilay D. Shah, PhD; Harlan M. Krumholz, MD, SM; and Joseph S. Ross, MD, MHS) Project Summary for IS - Oritavancin - Document - PDFSEARCH.IO

First Page	Meta Content
	Promoting Innovation in Drug Development: Understanding the Current Regulatory Environment Nicholas S. Downing, MD (with Nilay D. Shah, PhD; Harlan M. Krumholz, MD, SM; and Joseph S. Ross, MD, MHS) Project Summary for IS Add to Reading List Document Date: 2014-07-17 11:15:56 Open Document File Size: 32,99 KB Share Result on Facebook Currency USD / / MedicalCondition disease / certain diseases / / Organization House of Representatives / Food and Drug Administration / / Person Nilay D. Shah / Harlan M. Krumholz / Joseph S. Ross / / Technology Drug Development / / SocialTag Clinical research Pharmaceutical industry Clinical pharmacology Pharmacy Food and Drug Administration Clinical trial Drug discovery Blood substitute Oritavancin Pharmaceutical sciences

Promoting Innovation in Drug Development: Understanding the Current Regulatory Environment Nicholas S. Downing, MD (with Nilay D. Shah, PhD; Harlan M. Krumholz, MD, SM; and Joseph S. Ross, MD, MHS) Project Summary for ISAdd to Reading List